Although most follicular-derived thyroid cancers are well differentiated and have an overall
excellent prognosis following treatment with surgery and radioiodine, management of …

The treatment of patients with progressive metastatic follicular cell-derived and medullary
thyroid cancers that do not respond to standard therapeutic modalities presents a …

Anaplastic thyroid cancer cases with poor prognosis are associated with epigenetic
modifications such as abnormal DNA methylation. Epigallocathesin-3-gallate (EGCG) is a …

Background The frequent incidence of postsurgical recurrence issues in papillary thyroid
cancer (PTC) patients is a primary concern considering the low cancer‐related mortality …

Anaplastic thyroid carcinoma, BRAF non-V600, NRAS, combination immunotherapy and
targeted therapy, case report. Anaplastic thyroid carcinoma (ATC) is a rare type of thyroid …

Background: Liquid biopsy is a method that could potentially improve the management of
thyroid cancer (TC) by enabling the detection of circulating tumor DNA and RNA (ctDNA …

Introduction The most common altered signaling found in aggressive iodine-refractory
thyroid cancers derived from follicular cells (RAI-TC) are RTK, MAPK, PI3K, WNT, BRAF …

Objective The treatment landscape for thyroid cancers has changed rapidly with the
availability of kinase inhibitors against VEGFR, BRAF, MEK, NTRK, and RET. We provide an …

Purpose Fine-needle aspiration (FNA) biopsy is an effective method to discriminate
malignant thyroid nodules but reaches indeterminate results in approximately 30% of cases …

The dysregulation of autophagy is important in the development of many cancers, including
thyroid cancer, where V600EBRAF is a main oncogene. Here, we analyse the effect of …